Lansoprazole Teva

Lansoprazole, the active ingredient in Lansoprazole Teva, is a proton pump inhibitor presented as an oral tablet for gastroenteral use. It reduces gastric acid production and is used to treat conditions such as gastroesophageal reflux disease, peptic ulcer disease, and Helicobacter pylori infection in adults.

GNH USA supplies Lansoprazole Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lansoprazole is a proton pump inhibitor that acts on gastric acid secretion pathways. - Gastroesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of esophageal irritation. - Peptic ulcer disease: facilitates ulcer healing and reduces recurrence risk. - Helicobacter pylori eradication: used as part of combination therapy to improve eradication rates.

Lansoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually transient. - Nausea: occasional mild episodes. - Abdominal pain: mild discomfort. - Flatulence: increased gas. - Constipation: occasional.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing. - Clostridioides difficile infection: persistent diarrhea. - Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat. - Bone fractures: increased risk with long‑term use. - Liver enzyme elevation: jaundice, fatigue. - Acute interstitial nephritis: kidney inflammation.

Before initiating therapy, consider the following precautions. - Assess renal function: adjust use in severe impairment. - Evaluate for osteoporosis risk: long‑term therapy may affect bone density. - Monitor for infections: prolonged acid suppression can increase gastrointestinal infection risk. - Review concomitant medications: potential for altered absorption of drugs requiring acidic environment. - Pregnancy and lactation: use only if clearly needed after risk‑benefit assessment. - Store at ambient temperature: keep below 25°C, retain in original packaging, protect from moisture and light.

Lansoprazole may interact with several medicines; awareness of interaction severity is essential.

Major Interactions (Avoid): - Antifungal agents (e.g., ketoconazole, itraconazole): reduced absorption and efficacy. - HIV protease inhibitors (e.g., atazanavir): decreased plasma concentrations. - Clopidogrel: diminished antiplatelet effect.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR, monitor coagulation. - Methotrexate: increased serum levels, watch for toxicity. - Digoxin: altered absorption, check serum levels. - Diazepam: increased plasma concentration, monitor sedation.